Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 436-442

  Tsai, Tzu Hsien ^a   Chua, Sarah ^a   Hussein, Hisham ^a   Leu, Steve ^a   Wu, Chiung Jen ^a   Hang, Chi Ling ^a   Fang, Hsiu Yu ^a   Chung, Sheng Ying ^a   Fu, Morgan ^a   Chen, Huang Chung ^a   Chang, Li Teh ^b   Yeh, Kuo Ho ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

Author keywords

acute myocardial infarction; clinical outcome; Killip class III; primary percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ACUTE HEART INFARCTION; ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEVICE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; KILLIP CLASS III; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 79952184587     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206ccc3     Document Type: Article

References (36)

1. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-1442. (Pubitemid 27212192)
2. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276. (Pubitemid 27192468)
3. Chen JS, Ko WJ, Yu HY, et al: Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006; 34:950-957.
4. Killip T 3rd, Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20:457-464.
5. Goldberg RJ, Gore JM, Alpert JS, et al: Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community- wide perspective, 1975 to 1988. N Engl J Med 1991; 325:1117-1122.
6. Yip HK, Wu CJ, Chang HW, et al: Compari- son of primary angioplasty and conservative treatment on short- and long-term outcome in octogenarian or older patients with acute myocardial infarction. Jpn Heart J 2002; 43: 463-474.
7. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. Circulation 1993; 329: 1615-1622.
8. Simes RJ, Topol EJ, Holmes DR, et al: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995; 91:1923-1928.
9. Stone GW, Grines CL, Browne KF, et al: Predictors of in-hospital and 6- month outcome after acute myocardial infarction in the reperfusion era: The Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995; 25:370-377.
10. Yip HK, Wu CJ, Chang HW, et al: Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001; 87:1184 -1188; A4.
11. Antoniucci D, Valenti R, Santoro GM, et al: Systemic direct angioplasty and stentsupported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: In-hospital and long-term survival. J Am Coll Cardiol 1998; 31:294-300. (Pubitemid 28153446)
12. Sheu JJ, Tsai TH, Lee FY, et al: Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38: 1810-1817.
13. Grines CL, Browne KF, Marco J, et al: A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679. (Pubitemid 23073368)
14. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361:13-20. (Pubitemid 36050955)
15. Andersen HR, Nielsen TT, Rasmussen K, et al: A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742. (Pubitemid 37010777)
16. Widimský P, Budesínský T, Vorác D, et al: Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003; 24:94-104. (Pubitemid 36109551)
17. DeGeare VS, Boura JA, Grines LL, et al: Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001; 87:1035-1038. (Pubitemid 32710315)
18. Tsai TH, Chai HT, Sun CK, et al: Comparison of 30-day mortality between anterior- wall versus inferior- wall ST-segment elevation myocardial infarction complicated by cardiogenic shock undergoing primary coronary angioplasty. Cardiology 2010; 116:114-150.
19. Yip HK, Wu CJ, Chang HW, et al: Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003; 124:962-968.
20. Yip HK, Wu CJ, Chang HW, et al: Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol 2003; 92:1331-1335.
21. The TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase 1 findings. N Engl J Med 1985: 312: 932-936.
22. Yip HK, Wu CJ, Chen MC, et al: Effect of primary angioplasty on total or subtotal left main occlusion: Analysis of incidence, clinical features, outcomes, and prognostic determinants. Chest 2001; 120:1212-1217.
23. Cheng CI, Hsueh SK, Lee FY, et al: Clinical presentation and prognostic factors of patients with acute ST-segment elevation myocardial infarction following emergent revascularization for left main coronary obstruction. Circ J 2008; 72:1598-1604.
24. Stone GW, Grines CL, Browne KF, et al: Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: A comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn 1996; 39:333-339. (Pubitemid 127528449)
25. Yang SC, Hwang JJ, Hsu KL, et al: Predictors of in-hospital mortality in patients with successful primary coronary intervention for acute ST-elevation myocardial infarction presenting as cardiogenic shock. Acta Cardiol Sin 2010; 26:81-88.
26. Khot UN, Jia G, Moliterno DJ, et al: Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: The enduring value of Killip classification. JAMA 2003; 22;290: 2174-2181. (Pubitemid 37432978)
27. Pitt B, White H, Nicolau J, et al: Eplerenone reduces mortality 30 days post- randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005; 46:425-431. (Pubitemid 41040281)
28. Wu CJ, Chang HW, Hung WC, et al: N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2006; 70: 163-168.
29. Youssef AA, Change LT, Hang CL, et al: Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty. Circ J 2007; 71: 703-708. (Pubitemid 46683361)
30. Parikh CR, Coca SG, Wang Y, et al: Longterm prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008; 168:987-995. (Pubitemid 351679639)
31. Sonke GS, Beaglehole R, Stewart AW, et al: Sex differences in case fatality before and after admission to hospital after acute cardiac events: Analysis of community based coronary heart disease register. BMJ 1996; 313:853-855. (Pubitemid 26335208)
32. Cheng CI, Yeh KH, Chang HW, et al: Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 2004; 126:47-53.
33. Wiviott SD, Braunwald E, McCabe CH, et al: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357:2001-2015. (Pubitemid 350106708)
34. Stone GW, Witzenbichler B, Guagliumi G, et al: Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358:2218-2230. (Pubitemid 351724451)
35. Menon V, White H, LeJemtel T, et al: The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: A report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36: 1071-1076.
36. Menon V, Slater JN, White HD, et al: Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000; 108:374-380 (Pubitemid 30162955)